CBUS

MKT CAP:$68M

Cibus, Inc.

Market Cap

$68M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.48-$0.40 (-21.28%)

Apr 23, 2026

Company Details

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have hi...

CEO

Peter R. Beetham

IPO Date

Jul 20, 2017

Website

www.cibus.com

Key Metrics TTM

Revenue

$4M

+398.4% YoY

Net Income

-$289M

EPS (Diluted)

-$14.47

Free Cash Flow

-$61M

Revenue / Share

$0.07

Gross Margin

-31.2%

Operating Margin

-1986.1%

Net Margin

-7660.3%

FCF Margin

-1607.8%

P/S

18.0x

P/E

—

Earnings Reports

Q4 2025

May 14, 2026

PENDING

FY 2025

Mar 17, 2026

$4MEPS -$2.78

Q3 2025

Nov 13, 2025

$615.0KEPS -$0.44

Q4 2024

Mar 20, 2025

$1M+9.9%EPS -$0.87

Q2 2024

Aug 8, 2024

$838.0K+325.4%EPS -$1.14

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 20	$14M	-$5M	-$13M
Q1 21	$4M	-$2M	-$10M
Q2 21	$12M	$353.0K	-$6M
Q3 21	$8M	-$519.0K	-$7M
Q4 21	$2M	-$61.0K	-$7M
Q1 22	$32.0K	-$338.0K	-$6M
Q2 22	$41.0K	-$352.0K	-$7M
Q3 22	$42.0K	-$353.0K	-$6M
Q4 22	$42.0K	-$334.0K	-$3M
Q1 23	$42.0K	-$444.0K	-$4M
Q2 23	$197.0K	-$529.0K	-$19M
Q3 23	$475.0K	-$1M	-$26M
Q4 23	$1M	-$715.0K	-$20M
Q2 24	$838.0K	-$895.0K	-$21M
Q4 24	$1M	$1M	-$18M
Q3 25	$615.0K	-$779.0K	-$15M

Valuation

Quarter	P/S	P/E
Q4 20	6617.4x	—
Q1 21	8481.8x	—
Q2 21	4302.4x	—
Q3 21	3593.5x	—
Q4 21	2548.8x	—
Q1 22	1538.7x	—
Q2 22	866.7x	—
Q3 22	2529.8x	—
Q4 22	34081.8x	—
Q1 23	60098.5x	—
Q2 23	12105.4x	—
Q3 23	418.6x	—
Q4 23	214.1x	—
Q2 24	83.7x	—
Q4 24	18.9x	—
Q3 25	18.4x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 20	-$13M	-$13M
Q1 21	-$9M	-$10M
Q2 21	-$2M	-$2M
Q3 21	-$3M	-$3M
Q4 21	-$4M	-$4M
Q1 22	-$6M	-$7M
Q2 22	-$5M	-$6M
Q3 22	-$4M	-$5M
Q4 22	-$4M	-$4M
Q1 23	-$2M	-$2M
Q2 23	-$12M	-$12M
Q3 23	-$15M	-$18M
Q4 23	-$17M	-$17M
Q2 24	-$17M	-$17M
Q4 24	-$14M	-$14M
Q3 25	-$12M	-$12M

Capital Expenditures

Quarter	CapEx
Q4 20	$640.0K
Q1 21	$269.0K
Q2 21	$38.0K
Q3 21	$69.0K
Q4 21	$121.0K
Q1 22	$545.0K
Q2 22	$744.0K
Q3 22	$220.0K
Q4 22	$11.0K
Q1 23	$0
Q2 23	$560.0K
Q3 23	$3M
Q4 23	$449.0K
Q2 24	$169.0K
Q4 24	$56.0K
Q3 25	$108.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 20	+270.1%	+71.8%
Q1 21	+85.2%	+8.1%
Q2 21	+415.0%	+33.8%
Q3 21	+48.1%	+6.0%
Q4 21	-86.0%	-67.8%
Q1 22	-99.3%	-56.5%
Q2 22	-99.7%	-61.9%
Q3 22	-99.5%	-57.6%
Q4 22	-97.8%	-61.2%
Q1 23	+31.3%	-26.4%
Q2 23	+380.5%	+186.6%
Q3 23	+1031.0%	+320.7%
Q4 23	+2526.2%	+525.8%
Q2 24	+1895.2%	+395.4%
Q4 24	+515.2%	-1.4%
Q3 25	+29.5%	-38.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 20	$1M	9.6%
Q1 21	$0	0.0%
Q2 21	$1M	9.1%
Q3 21	$1M	15.9%
Q4 21	$1M	63.0%
Q1 22	$531.0K	1659.4%
Q2 22	$1M	3229.3%
Q3 22	$1M	2464.3%
Q4 22	$1M	2638.1%
Q1 23	$828.0K	1971.4%
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	0.0%
Q2 24	$0	0.0%
Q4 24	$0	0.0%
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q4 20	$3M	$3M	$1M	—
Q1 21	$3M	$4M	—	—
Q2 21	$3M	$3M	—	—
Q3 21	$3M	$4M	—	—
Q4 21	$3M	—	—	$4M
Q1 22	$3M	—	—	$3M
Q2 22	$3M	—	—	$3M
Q3 22	$3M	—	—	$3M
Q4 22	$2M	—	—	$633.0K
Q1 23	$2M	—	—	$2M
Q2 23	$8M	—	—	$10M
Q3 23	$18M	—	—	$7M
Q4 23	$14M	—	—	$5M
Q2 24	$13M	—	—	$8M
Q4 24	$12M	—	—	$7M
Q3 25	$11M	—	—	$4M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$17M	$0	$17M
Q2 22	$11M	$0	$11M
Q3 22	$7M	$0	$7M
Q4 22	$3M	$0	$3M
Q1 23	$2M	$0	$2M
Q2 23	$51M	$0	$51M
Q3 23	$32M	$0	$32M
Q4 23	$33M	$0	$33M
Q1 24	$25M	$0	$25M
Q2 24	$30M	$0	$30M
Q3 24	$29M	$0	$29M
Q4 24	$14M	$0	$14M
Q1 25	$24M	$0	$24M
Q2 25	$36M	$0	$36M
Q3 25	$24M	$0	$24M
Q4 25	$10M	$0	$10M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 20	726M	+9.3%	+10.1%
Q1 21	743M	+2.4%	+12.6%
Q2 21	744M	+0.2%	+12.6%
Q3 21	746M	+0.2%	+12.3%
Q4 21	766M	+2.7%	+5.5%
Q1 22	578M	-24.4%	-22.1%
Q2 22	578M	0.0%	-22.2%
Q3 22	578M	0.0%	-22.4%
Q4 22	578M	0.0%	-24.4%
Q1 23	578M	0.0%	0.0%
Q2 23	578M	0.0%	0.0%
Q3 23	391M	-32.3%	-32.3%
Q4 23	17M	-95.6%	-97.0%
Q2 24	22M	+26.7%	-96.2%
Q4 24	27M	+21.5%	-95.4%
Q3 25	53M	+99.4%	-86.5%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 20	—	—
Q1 21	—	—
Q2 21	—	—
Q3 21	—	—
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	$6.0K	183
Q2 24	$4.6K	183
Q4 24	$7.6K	159
Q3 25	$3.9K	159

Revenue / Employee